Philips issues security advisory for cardiac PACS software
Philips Healthcare and the U.S. Department of Homeland Security's Industrial...Read more on AuntMinnie.comRelated Reading: Philips grows medical sales and profit in Q2 Philips wins FDA clearance for Ingenia Elition MRI scanner Philips to implement Dana-Farber's cancer support tool Philips, AHA to launch $30M venture capital fund Philips issues security advisory for PACS software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2018 Category: Radiology Source Type: news

Davis-based Expanesthetics raises another $1.16 million in venture capital
Davis-based pharmaceutical company Expanesthetics Inc. has raised another $1.16 million in venture capital, according to a recent Securities and Exchange Commission filing.   The 6-year-old company is developing alternatives to general anesthetics. Expanesthetics is the sole licensee of a patented anesthetic technology originally researched through programs associated with the University of California. The latest round of investment was funded by existing shareholde rs, over half of whom are anesthesiologists… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 14, 2018 Category: Pharmaceuticals Authors: Felicia Alvarez Source Type: news

Davis-based Expanesthetics raises another $1.16 million in venture capital
Davis-based pharmaceutical company Expanesthetics Inc. has raised another $1.16 million in venture capital, according to a recent Securities and Exchange Commission filing.   The 6-year-old company is developing alternatives to general anesthetics. Expanesthetics is the sole licensee of a patented anesthetic technology originally researched through programs associated with the University of California. The latest round of investment was funded by existing shareholde rs, over half of whom are anesthesiologists… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 14, 2018 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Device Safety and Regulations Questioned in The Bleeding Edge
Netflix’s movie, The Bleeding Edge, is about allegedly unsafe medical devices, how they got to market, and how difficult it is to get them off the market. Living in New York, I actually saw it in a movie theater. It has also received a modest amount of press with various radio, print, and online interviews. The principals behind the movie, Kirby Dick, Amy Ziering, and Amy Herdy, are established documentary filmmakers as is evidenced by the high production values that go well beyond talking heads and statistics. The issue of faulty medical devices is approached through the personal stories of v...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: William A. Hyman Tags: Regulatory and Compliance Source Type: news

Phoenix bioscience firm raises $8.9M in venture capital for genetic profiling test
The company's sequencing test identifies cancer tumors to personalize a patient's treatment plan. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 2, 2018 Category: American Health Authors: Angela Gonzales Source Type: news

Phoenix bioscience firm raises $8.9M in venture capital for genetic profiling test
The company's sequencing test identifies cancer tumors to personalize a patient's treatment plan. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 2, 2018 Category: Biotechnology Authors: Angela Gonzales Source Type: news

Columbus A.I.-based healthcare startup closes $32.8M investment round
A Columbus AI healthcare startup has closed on another round of venture capital. Olive Inc. announced on Tuesday the $32.8 million Series D round that was led by venture capital firms Oak HC/FT and Ascension Ventures, with additional funding from existing investors. This is the second investment in seven months for the five-year-old company formerly known as CrossChx. Columbu s-based Olive said in a statement that the additional capital would help it scale its flagship product, an artificial intelligence-driven… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 31, 2018 Category: Biotechnology Authors: Tristan Navera Source Type: news

These 25 local startups raised more than $870M in July
This article originally appeared on  Bostinno. July was eventful for Boston-area startups. The major rounds included Indigo’s blockbuster $300 million deal, Toast raising $115 million, and Flywire and Starry each netting $100 million. It was a great month for venture capital funds, too. Early-stage VC firm Glasswing Ventures  announced its debut fund focused on artificial intelligence startups. The $112 million fund is the largest AI-focused fund on the East Coast, and seeks to capitalize… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 31, 2018 Category: Health Management Authors: Srividya Kalyanaraman Source Type: news

Meet the Silicon Valley Business Journal's 40 under 40 Class of 2018
Our 2018 honorees include CEOs, entrepreneurs and even a few second acts from startups to venture capital, real estate to law, and fitness to nonprofits. Explore them all here. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 27, 2018 Category: Biotechnology Source Type: news

Meet the Silicon Valley Business Journal's 40 under 40 Class of 2018
Our 2018 honorees include CEOs, entrepreneurs and even a few second acts from startups to venture capital, real estate to law, and fitness to nonprofits. Explore them all here. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 26, 2018 Category: Pharmaceuticals Source Type: news

Six Ways Artificial Intelligence Is Impacting Patients
It ’s difficult to open a newspaper nowadays without seeing an article about artificial intelligence. These column-inches spark our imaginations with heady visions of possible futures and crease our brows with concern in equal measure. But one thing you cannot escape is that AI is here now and it’s only going to become more pervasive.While fear of an unknown technology is understandable, in many ways it does a disservice to the incredible impact that AI is already having on the world around us. In the healthcare space alone, it is offering ways to fundamentally rethink clinical practice, speeding up diagnosis, ...
Source: EyeForPharma - July 24, 2018 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

Sanofi's venture arm backs 'digital' drug startup Click Therapeutics
Sanofi Ventures, the Cambridge-based venture capital arm of French drugmaker Sanofi (NYSE: SNY), led a $17 million round on Monday for a New York startup that is creating digital tools to help people quit smoking, manage chronic pain and treat other disorders. Click Therapeutics, which was founded in 2012, is part of the emerging field of "digital therapeutics." The company launched a smoking cessation app called Clickotine last year and is developing digital treatments for depression, insomnia,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 23, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Philips grows medical sales and profit in Q2
Royal Philips saw revenue grow 8% after currency adjustments in the second...Read more on AuntMinnie.comRelated Reading: Philips wins FDA clearance for Ingenia Elition MRI scanner Philips to implement Dana-Farber's cancer support tool Philips, AHA to launch $30M venture capital fund Report: Philips to cut more jobs in Cleveland Long-term deals and AI drive Q1 sales growth at Philips (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 23, 2018 Category: Radiology Source Type: news

Ohio Innovation Fund leads $7M round in Athens drugmaker
A pharmaceutical maker addressing critical drug shortages will fledge from an Ohio University incubator and add as many as 100 jobs in rural Athens County after closing a $7 million funding round. RXQ Compounding LLC will use the round to add to its management team and expand operations in its new manufacturing facility in Albany, a village with just more than 800 residents about 10 minutes from Athens. Ohio Innovation Fund, the venture capital firm backed by Ohio State, Ohio and Kent Stat e universities,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 23, 2018 Category: American Health Authors: Carrie Ghose Source Type: news

Medtech companies raised more than $738 million in Q2
[Image from unsplash.com]Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. Medical device and equipment companies raised a total of $738,600,000 during the second quarter. In contrast, medical device and equipment companies raised $739,750,000 during Q1. Compared to the second quarter of 2017, investments are down $1.5 million, but there were four more ...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News Acutus Medical Avedro Axonics Modulation Cardiac Dimensions Cardiofocus Cytrellis Biosystems Eargo Mevion Medical Systems RefleXion Medical Relievant Medsystems venture capital Source Type: news

Medical device, network security company CyberMDX bags $10M Series A
CyberMDX, a connected medical device and clinical network security firm, announced today that it has closed $10 million in Series A funding. The financing round was led by Pitango Venture Capital, with additional backing from OurCrowd Qure. The company ’s MDefend software product is deployed to a provider’s network, CyberMDX CEO Amir Magner told MobiHealthNews. The tool is non-intrusive, and doesn’t apply any software within the protected devices themselves. (Source: mobihealthnews)
Source: mobihealthnews - July 17, 2018 Category: Information Technology Source Type: news

CyberMDX closes $10m Series A
Healthcare cybersecurity group CyberMDX said today it closed a $10 million Series A round of financing. The Series A round was led by Pitango Venture capital and joined by OurCrowd Qure, the New York-based company said. CyberMDX provides non-intrusive solutions related to risk management and threat prevention and detection functionality for medical devices and other internet of medical things devices. “The expedited growth of connected medical devices poses exceptional challenges for hospital network security. Connected devices have become an integral part of hospitals’ IT networks, yet they are not monitored a...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Software / IT cybermdx Cybersecurity Source Type: news

This is why Chinese tech giant Tencent is interested in RTP bioscience firm
Ties to Chinese technology giant Tencent and San Francisco-based venture capital firm ARTIS Ventures are propelling Locus Biosciences to the next level.   Research Triangle Park-based Locus caught the attention of Tencent and ARTIS last year – that is, when it came to substantial investments from both companies.  Last summer, Locus secured a $5 million convertible note, with Tencent Holdings leading the financing round that also included the N.C. Biotechnology Center. And later in the year,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 17, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news

Polares Medical raises $25m
Preclinical Swiss medtech group Polares Medical said today it closed a $25 million funding round to support its mitral valve repair technologies. Funding in the round was led by Decheng Capital and joined by Endeavour Vision, IDO Investments, Earlybird Venture Capital and Wellington Partners, the company said. Polares Medical is developing a “hemi-replacement” solution for the mitral valve through which the posterior leaflet is replaced with a prosthetic leaflet designed to enhance coaptation with the native anterior leaflet. “Hemi-replacement represents a new treatment paradigm for mitral regurgitation, ...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Funding Roundup polaresmedical Source Type: news

Atlas, Sofinnova lead $45M investment in cancer startup
The founders of a small Cambridge startup helping to develop more effective drugs for cancer, autoimmune disorders and liver diseases like NASH are planning to double staff after closing a $45 million Series A venture capital investment. The startup, HotSpot Therapeutics Inc., has developed a platform it calls SpotFinder, which it says can better identify protein targets or "hotspots," to enable drugmakers to develop more potent medications for a variety of diseases. "What's exciting about HotSpot… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 17, 2018 Category: Health Management Authors: Allison DeAngelis Source Type: news

Fresenius put $2m into Vectorious Medical ’ s $10m Series B
Fresenius (NYSE:FMS) said today that its venture arm put $2 million into a Series B round for Vectorious Medical Technologies that brought in a total of nearly $10 million for the cardiac implant company. Tel Aviv-based Vectorius is developing the V-Lap implantable wireless heart monitor, which is designed to monitor pressure in the heart’s left atrium. The $9.5 million Series B round in March was led by Boston venture capital shop Broadview Ventures and China’s GEOC and individual investors, plus a $2.2 million grant from the European Union’s Horizon 2020 R&D program and...
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Implants Funding Roundup Patient Monitoring Wall Street Beat Fresenius Vectorious Medical Technologies Source Type: news

AED startup HeartHero raises $2m in seed funding
Medtech startup HeartHero said this week it raised $1.5 million in a seed investment round to support the development of its next-gen automated external defibrillators. HeartHero is developing a portable, “easy-to-use” AED with intentions of making the device affordable to the general populace. The Denver-based company said the $1.5 million was over its initial funding goal, and that funds in the round came from a venture capital firm, angel investors and grant funding. “Now that we have closed our seed round of funding, we are one step closer to empowering millions to save their loved ones from a cardiac...
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiac Assist Devices Cardiovascular hearthero Source Type: news

Amount of venture capital raised by Maryland companies increases 142 percent in 2Q
Maryland companies raised $247 million in venture capital funding in the second quarter, the sixth consecutive quarter the state has raised at least $100 million. The state had 23 deals, up from 20 in the first quarter and 17 in the prior-year quarter, according to the PwC/CB Insights MoneyTree Report released Thursday. The total dollar amount was up 142 percent from $102.3 million a year ago but down 39 percent from $408 million in the fourth quarter. Mar yland ranked 11th nationally for number… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 12, 2018 Category: Health Management Authors: Holden Wilen Source Type: news

Amount of venture capital raised by Maryland companies increases 142 percent in 2Q
Maryland companies raised $247 million in venture capital funding in the second quarter, the sixth consecutive quarter the state has raised at least $100 million. The state had 23 deals, up from 20 in the first quarter and 17 in the prior-year quarter, according to the PwC/CB Insights MoneyTree Report released Thursday. The total dollar amount was up 142 percent from $102.3 million a year ago but down 39 percent from $408 million in the fourth quarter. Mar yland ranked 11th nationally for number… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2018 Category: Biotechnology Authors: Holden Wilen Source Type: news

Healthcare VC Investing Could Hit A Record High In 2018
In the second quarter alone, $5.3 billion in venture capital was invested in 216 healthcare deals, placing the sector at number two on the list of the top five fundraisers. And all signs are pointing to continued investor enthusiasm for the sector. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 12, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

Adlai Nortye Raises $53M in Series B
HANGZHOU, China, July 5, 2018 -- (Healthcare Sales & Marketing Network) -- Adlai Nortye Biopharma Co., Ltd. ("Adlai Nortye" or "the Company"), a biopharmaceutical company, announced that it has raised $53 million in a Series B financin... Biopharmaceuticals, Oncology, Venture Capital Adlai Nortye Biopharma, Reolysin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2018 Category: Pharmaceuticals Source Type: news

I-Mab Successfully Raised USD 220 Million in Series C Funding
SHANGHAI, June 29, 2018 -- (Healthcare Sales & Marketing Network) -- I-Mab Biopharma, a company focusing on innovative Biologics in therapeutic areas of immuno-oncology and immuno-inflammation, announced the completion of Series C financing for USD 220 mi... Biopharmaceuticals, Oncology, Venture Capital I-Mab Biopharma, Genexine, HyLeukin, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2018 Category: Pharmaceuticals Source Type: news

Amazon to buy online pharmacy
Amazon has announced that it will be buying the venture capital-backed startup, PillPack. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 28, 2018 Category: Pharmaceuticals Source Type: news

Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
Initial applications to focus on the treatment of solid tumor malignancies Clinical trials expected to begin in 2019 PHILADELPHIA, June 27, 2018 -- (Healthcare Sales & Marketing Network) -- Carisma Therapeutics Inc., formerly CARMA Therapeutics, a p... Biopharmaceuticals, Venture Capital Carisma Therapeutics, macrophage, immunotherapeutics, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2018 Category: Pharmaceuticals Source Type: news

Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Company to open corporate headquarters in Minneapolis, MN MINNEAPOLIS, June 26, 2018 -- (Healthcare Sales & Marketing Network) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back ... Devices, Orthopaedic, Neurosurgery, Venture Capital Relievant Medsystems, low back pain, Intracept, basivertebral nerve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 26, 2018 Category: Pharmaceuticals Source Type: news

McKesson Ventures Donates $10,000 to Meals on Wheels America on Behalf of Landmark Health
SAN FRANCISCO  – June 26, 2018 – McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that it has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a leading provider of in-home, risk-based medical care. As part of its... (Source: McKesson News)
Source: McKesson News - June 26, 2018 Category: Information Technology Source Type: news

Hospital billing platform Cedar secures $36M in venture capital
New York-area startups and venture capitalists are making funding deals with the hopes of creating the next profitable company. Here's one deal announced Monday: Who gets: Cedar, the patient billing management platform for hospitals and medical groups, announced a Series B fundraising round. Amount raised: $36 million. The round comes just seven months after Cedar received $13 million in Series A funding. Who invests: Kinnevik led the campaign alongside existing investors Founders Fund and Thrive… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 25, 2018 Category: Health Management Authors: Anthony Noto Source Type: news

Dementia venture fund raises $350 million to hunt new drugs
LONDON (Reuters) - A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target of $200 million set on its launch in 2015. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases
Financing led by Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures Company Announces Licensing Agreement with Amgen CAMBRIDGE, Mass., June 25, 2018 -- (Healthcare Sales & Marketing Network) -- Akero Therapeutics, Inc., a biote... Biopharmaceuticals, Licensing, Venture Capital Akero Therapeutics, Amgen, non-alcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2018 Category: Pharmaceuticals Source Type: news

Medtech venture investing trends: Here ’ s what you need to know
Ask any early-stage medtech or digital health entrepreneur, and they’ll tell you how tough it is. There’s tremendous competition for venture investing, coupled with a pullback by previously traditional investors in this space. Bill Evans [Image from Nick Morrison on Unsplash]While venture investment in medtech and digital health has recovered since the financial crisis of a decade ago — setting a record in 2017 — this doesn’t reflect what it’s like for entrepreneurs raising money at that critical transition from seed money to Series A. The bar for new investments is considerably raised, ...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Funding Roundup mHealth (Mobile Health) billevans Medtech Innovator Silicon Valley Bank startups venture capital Source Type: news

Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Capital will fuel continued research and clinical development of micro-infusion platform EMERYVILLE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Mercator MedSystems, Inc., today announced it has received $11 million in Series D e... Devices, Interventional, Venture Capital Mercator MedSystems, Shenzhen Salubris Pharmaceuticals, Bullfrog, Micro-Infusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics
EDINBURGH, Scotland, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million inves... Biopharmaceuticals, Oncology, Venture Capital AdoRx Therapeutics, adenosine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Alpha Biopharma Announces Series A Financing
SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita... Biopharmaceuticals, Oncology, Venture Capital, Personnel Alpha Biopharma, NSCLC, tyrosine kinase inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Peter Thiel fund invests in Boston-based 'organs-on-chips ’ startup
Emulate Inc., a Boston-based startup that is developing “organs-on-chips” for testing experimental drugs, has a prominent new investor: Founders Fund, the San Francisco-based venture capital firm co-founded by billionaire Peter Thiel. Emulate announced Tuesday that it has secured a $36 million Series C round led by Founders Fund. The VC firm was an early investor in Facebook; its portfolio also includes Airbnb, Elon Musk’s rocket manufacturer SpaceX, and Thiel’s data-mining company Palantir. Emulate… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 19, 2018 Category: American Health Authors: Max Stendahl Source Type: news

StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Financing Will Enable Stride to Move Multiple Programs Towards the Clinic DURHAM, N.C., June 13, 2018 -- (Healthcare Sales & Marketing Network) -- StrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies announced toda... Biopharmaceuticals, Venture Capital, Personnel StrideBio, gene therapy, gene editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Bill & Melinda Gates Foundation, Li Ka Shing Foundation Lead New Funding Round to Expand Groundbreaking Progress in Restoring Infant Gut Microbiome and to Lay a Global Foundation for Long-Term Nutritional and Immune Health DAVIS, Calif., June 13, 2018 -... Biopharmaceuticals, Gastroenterology, Venture Capital Evolve BioSystems, microbiome, gut microbiome, Evivo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
HAIFA, Israel, June 13, 2018 -- (Healthcare Sales & Marketing Network) -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it's subsidiary, Beyeonics Surgical Ltd. ("Beyeonics"), concluded a first r... Devices, Surgery, Venture Capital Elbit Systems, Beyeonics Surgical, Clarity Bionic Visualization (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
MINNEAPOLIS, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Vergent Bioscience, a cancer-focused biotechnology company, announced today that it raised $8.7 million in a Series A financing round led by Spring Mountain Capital to fund its precli... Diagnostics, Oncology, Venture Capital Spring Mountain Capital, Vergent Bioscience, fluorescent probe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

Propeller Health Raises Strategic Investment from McKesson Ventures
MADISON, Wis., June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital therapeutics company, announced a strategic investment of an undisclosed amount from McKesson Ventures, adding to the $20M funding round announce... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines, Asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Gaithersburg biopharma company Sirnaomics raises $25M
Key story highlights: Gaithersburg-based Sirnaomics Inc. has raised $25 million in Series C1 funding. The company, which develops anti-fibrosis and anti-cancer RNAi therapeutics, will use the capital to push forward its clinical programs, expand development of new drug candidates and grow its management team. It last r aised $10 million in a Series B round in 2016, which followed previous venture capital investment and grant funding totaling $25 million at that time. Gaithersburg's Sirnaomics… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 7, 2018 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

BIOMODEX Raises an Additional $15M in Series A Funding
Latest investment from Idinvest Partners and InnovAllianz to support technological development and enable the opening a manufacturing facility in Massachusetts Boston, June 07, 2018 -- (Healthcare Sales & Marketing Network) -- BIOMODEX, a medical devic... Devices, Venture Capital BIOMODEX, 3D Printing, synthetic organ (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

SutroVax Announces $85M Series C Financing led by TPG Growth
Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board Chairman Strategic alignment established with Lonza Pharma & Biotech to create end-to-end supply chain ... Biopharmaceuticals, Venture Capital, Personnel SutroVax, pneumococcal vaccine, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China
BOSTON and SHANGHAI, June 7, 2018 -- (Healthcare Sales & Marketing Network) -- Oncologie, an innovative biopharmaceutical company, announced today that it is launching operations in both Boston and Shanghai with $16.5M seed financing led by Pivotal bioVen... Biopharmaceuticals, Oncology, Venture Capital Oncologie, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

DRIVe (Division of Research, Innovation, and Ventures)
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. 06/2018 This program, established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Assistant Secretary for Preparedness and Response (ASPR), takes a new approach to tackle the biggest national health security threats by developing innovative technologies and practices for transformative solutions. It brings together the best ideas from the medical and scientific communities, together with government and venture capital investment, to drive innovation that will strengthen the natio...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 6, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news